DLD-1 Cells

Unit

3 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Intestine cancer cell lines

Organism

Human

Donor History

Adenocarcinoma

Growth Properties

Adherent

Growth Conditions

Culture medium: RPMI 1640

,

w: 2.0 mM stable Glutamine

,

w: 2.0 g/L NaHCO3 (Cytion article number 820700a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Seeding density: 1 to 2 x 10⁴ cells/cm². Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/DLD-1-Cells/300220

SKU: 300220 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

DLD-1 is a human colorectal adenocarcinoma cell line derived from the distal colon of an adult patient. These cells are epithelial in morphology and were initially established to study colorectal cancer mechanisms and pathology. DLD-1 cells are commonly used in oncology research, particularly in studies focusing on the molecular biology of cancer, gene expression, and the effects of various chemotherapeutic agents.

This cell line is known for its heterozygous KRAS mutation at codon 13, which is a common feature in colorectal cancers, implicating it in cancer cell survival and proliferation. Additionally, DLD-1 exhibits mutations in the APC gene, contributing to the deregulation of the Wnt signaling pathway, a critical element in colorectal carcinogenesis. The robust use of DLD-1 in research provides valuable insights into tumor behavior, drug response, and cancer genetics, making it a vital model in colorectal cancer research and therapeutic development.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.